Login
← Go Back
Marksans Pharma
MARKSANS · Pharma > Pharmaceuticals & Drugs · Chairman: Mark Saldanha · MD: Mark Saldanha · Listing date: Jan. 22, 2002 · Employees: 1138 · Mumbai · http://www.marksanspharma.com
Stock Price vs Company Growth
1d
2.5%
1w
1.4%
1m
0.3%
3m
36.9%
6m
59.5%
1y
13.8%
5y
26.4%
10y
18.7%
all
17.8%
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 257 2.5%
181
281
Company Overview
Sales
2,951 Cr
Growth: 12.2%
Profit after Tax
418 Cr
Growth: 16.0%
Mid Cap
11,637 Cr
P/E: 27.8x
Industry P/E: 32.3x
Fundamentals
Sales (Cr) ₹ 2,951
Growth 12.2%
EBITDA 20.4%
P/S 3.9x
Dividend 0.4%
P/E 27.8x
Book Value ₹ 66.7
PEG Ratio 2.3x
ROE 15.3%
P/B 3.9x
Shareholding Pattern
Institutions
Promoters
Mark Saldanha
48.25 %
Others
Mukul Mahavir Prasad Agrawal
1.47 %
Increase    Decrease    No change
Company Profile Detailed
The company is a globally-trusted, customer-centric pharmaceutical company with a strong presence in regulated markets. The company specialises in developing and manufacturing & distributing both over-the-counter (OTC) and prescription (Rx) drugs, aligning its offerings with the evolving needs of patients and healthcare providers across the world.
Belongs to (13 Indices) view more
Investors (49)
mondrian...
kaushik5
sandra.d...
Followers (8)
akash2
karan3
sachin3